Skip to main content
SpringerLink
Log in

Treatment Aspects of “International” Asthma Europe

  • Chapter
Bronchial Asthma

  • 121 Accesses

Abstract

This chapter will discuss European trends in asthma management, with special focus on bronchial inflammation treatment. Future strategies in asthma therapy will also be briefly discussed. An European practical approach of asthma treatment is proposed. Asthma is a bronchial disease characterized by airway obstruction, hyperresponsiveness, and inflammation. The inflammatory component is currently considered essential for the appearance or recurrence of the clinical symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. British Thoracic Society, Research Unit of the Royal College of Physicians of London, King’s Fund Centre, National Asthma Campaign. Guidelines for management of asthma in adults: I-chronic persistent asthma. Br. Med. J. 1990; 301:651–653.

    Article  Google Scholar 

  2. Bendefy IM. Home nebulizers in childhood asthma: survey of hospital supervised use. Br. Med. J. 1991; 302:1180–1181.

    Article  CAS  Google Scholar 

  3. Palmer JBD. Beta-agonists, in International Conference on New Drugs for Asthma (Barnes P, ed.), I.B.C., London, 1989.

    Google Scholar 

  4. Kraan J, Koeter GH, Mark TW, Sluiter HJ, and de Vries K. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with anti-asthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. J. Allergy Clin. Immunol. 1985; 76:628–636.

    Article  PubMed  CAS  Google Scholar 

  5. Wong CS, Pavord ID, Williams J, Britton JR, and Tattersfield AEI. Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet 1990; 336:1396–1399.

    Article  PubMed  CAS  Google Scholar 

  6. Fitzpatrick MF, Mackay T, Driver H, et al. Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled β2 agonist. Br. Med.J. 1990; 301:1365–1368.

    Article  CAS  Google Scholar 

  7. Faulds D, Hollingshead LM, and Goa KL. Formoterol: a review of its Pharmacological properties and therapeutic potential in reversible obstructive airways disease. Drugs 1991; 42:115–137.

    Article  PubMed  CAS  Google Scholar 

  8. Barnes PJ. A new approach to the treatment of asthma. N. Eng. J. Med. 1989; 30:1517–1527.

    Google Scholar 

  9. Barnes PJ. Overview of current therapy, in International Conference on New Drugs for Asthma (Barnes P, ed.), I.B.C., London, 1991.

    Google Scholar 

  10. Sears MR, Taylor DR, Print CG, Lake DC, Quingqing L, Flannery EM, Yates DM, Lucas MK, and Herbison GP. Regular inhaled beta-agonists treatment in bronchial asthma. Lancet 1990; 336:1391–1396.

    Article  PubMed  CAS  Google Scholar 

  11. Shovlin CL and Tam FWK. Salbutamol nebuliser and precipitation of critical cardiac ischaemia. Lancet 1990; 335:1258.

    Article  Google Scholar 

  12. Gross NJ. Ipratropium bromide. N. Eng. J. Med. 1988; 319:486–494.

    Article  CAS  Google Scholar 

  13. Palma-Carlos AG. Basic aspects of therapy in intrinsic asthma. Agents Actions 1989; 28:263–2

    CAS  Google Scholar 

  14. Palma-Carlos AG. Xanthines in the treatment of bronchial asthma, in Advances in Bronchial Asthma (Oehling A and Cortes J, eds.),Garsi, Madrid, 1986; pp. 187–190.

    Google Scholar 

  15. Pearson CG. Xanthines as antiinflammatory drugs. J. Allergy Clin. Immunol. 1988; 81:615–617.

    Article  Google Scholar 

  16. British Thoracic Society, Research Unit of the Royal College of Physicians of London, King’s Fund Centre, National Asthma Campaign. Guidelines for management of asthma in adults: II-Acute severe asthma. Br. Med. J. 1990; 301:797–800.

    Article  Google Scholar 

  17. Anderson KE and Person CGA. The clinical pharmacology of enprophylline and theophylline, in Anti-Asthma Xanthines and Adenosine (Anderson KE and Person CGA, eds.), Excerpta Medica, Amsterdam, 1985; pp. 41–55.

    Google Scholar 

  18. Pauwels R, Van Rentherghem D, Van der Straeten M, Johanneson N, and Pearson CG. The effect of theophylline and enprophylline on allergen induced bronchoconstriction. J. Allergy Clin. Immunol. 1985; 76:583–590.

    Article  PubMed  CAS  Google Scholar 

  19. Brattsand R. New glucocorticosteroids, in International Conference on New Drugs for Asthma (Barnes P, ed.), I.B.C., London, 1991.

    Google Scholar 

  20. Gray R, Harrington C, Coulton L, Calloway J, de Broe M, and Kanis J. Long-term treatment of chronic inflammatory disorders with deflazacort. J. Orthop. Rheumatol 1990; 3:15–27.

    Google Scholar 

  21. Kraan J, Koeter GH, Mark TW, Sluiter HJ, and de Vries KI. Dosage and time effects of inhaled budesonide on bronchial hyperreactivity. Am. Rev. Resp. Dis. 1988; 76:628–636.

    Google Scholar 

  22. Juniper EF, Kline PA, Vanzieleghem MA, and Hargreave FE. Reduction of budesonide after a year of increased use: a randomized controlled trial to evaluate whether improvements an airway responsiveness and clinical asthma are maintained. J. Allergy Clin. Immunol. 1991; 87:483–489.

    Article  PubMed  CAS  Google Scholar 

  23. Svendsen UG, Frolund L, Madsen F, Nielsen NH, Holstein-Rathau NH, and Weeke B. A comparison of the effects of sodium cromoglycate and beclomethasone dipropionate on pulmonary function and bronchial hyperreactivity. J. Allergy Clin. Immunol. 1987; 80:68–74.

    Article  PubMed  CAS  Google Scholar 

  24. Rocchiccioli KMS and Riley PA. Clinical pharmacology of Nedocromil sodium. Drugs 1989; 37:123–126.

    Article  PubMed  Google Scholar 

  25. Grant SM, Goa, KL, Fitton A, and Sorkin EM. Ketotifen: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders. Drugs 1990; 40:412–448.

    Article  PubMed  CAS  Google Scholar 

  26. McTavish D, Goa KL, and Ferrill M. Terfenadine: an updated review of its pharmacological properties and therapeutic efficacy. Drugs 1990; 39:552–574.

    Article  PubMed  CAS  Google Scholar 

  27. Menz G, Bode E, and Schmitz-Schumann M. Experience with steroid-sparing treatment of severe corticosteroid dependent asthma. Atmw-Lungenkrkh. Jahrgang. 1990; 16:(Suppl. l):6–

    Google Scholar 

  28. Mullarkey MF, Blumenstein BA, Andrade WP, Bailey GA, Olason I, and Wetzel CE. Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study. N. Eng. J. Med. 1988; 318:603–607.

    Article  CAS  Google Scholar 

  29. Shinner RJ, Nunn AJ, Chung KF, and Geddes D. Randomized double-blind, placebo-controlled trial of Methotrexate in steroid-dependent asthma. Lancet 1990;336:137–140.

    Article  Google Scholar 

  30. Alexander AG, Barnes NC, and Kay AB. Cyclosporin A in chronic severe asthma: a double-blind, placebo-controlled trial. Am. Rev. Resp. Dis. 1991; 143:633A.

    Google Scholar 

  31. Barnes NC. Leukotrienes antagonists, in International Conference on New Drugs for Asthma (Barnes P, ed.), I.B.C., London, 1991.

    Google Scholar 

  32. Alabaster, VA. PAF antagonists, in International Conference on New Drugs for Asthma (Barnes P, ed.), I.B.C., London, 1991.

    Google Scholar 

  33. Weeke B. The future of Immunotherapy. Clin. Exp. Allergy 1991; 21(Suppl. l):86–92.

    Article  Google Scholar 

  34. CSM-update. Desensitising vaccines. Br. Med. J. 1986; 293:948.

    Article  Google Scholar 

  35. EAACI Immunotherapy subcommittee. Mailing HJ, ed. Immunotherapy-position paper. Allergy 1988; 43(Suppl. 6):9–33.

    Google Scholar 

  36. WHO/IUIS working group. The current status of allergen immunotherapy (hyposensitisation). Allergy 1989; 44:369–379.

    Article  Google Scholar 

  37. Durhan SR, Varney V, Gaga M, Frew AJ, Jacobson M, and Kay AB. Immunotherapy and allergic inflammation. Clin. Exp. Allergy 1991; 21:206–210.

    Article  Google Scholar 

  38. Noon I. Prophylactic inoculation against hay fever. Lancet 1991; i: 1572–1573.

    Google Scholar 

  39. Gwynne J, Mierins E, and Karsh J. Methotrexate-induced asthma. Am. Rev. Resp. Dis. 1991; 143:179–181.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 1st Medical Clinic and lmmunology Institute, Lisboa Cedex, Portugal

    A. G. Palma-Carlos & A. Lorena Jordão

Authors
  1. A. G. Palma-Carlos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Lorena Jordão
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of California School of Medicine, Davis, CA, USA

    M. Eric Gershwin  & Georges M. Halpern  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

Palma-Carlos, A.G., Jordão, A.L. (1994). Treatment Aspects of “International” Asthma Europe . In: Gershwin, M.E., Halpern, G.M. (eds) Bronchial Asthma. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-0297-4_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-0297-4_20

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4612-6697-6

  • Online ISBN: 978-1-4612-0297-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation